The European Union has accused AstraZeneca of lack of clarity and said the company had provided “insufficient explanations” for delays in supplying its Covid-19 vaccine to member states.
“Discussions with @AstraZeneca today resulted in dissatisfaction with the lack of clarity and insufficient explanations,” the European Commissioner for Health, Stella Kyriakides, tweeted after a meeting with the pharmaceutical giant on Monday. “EU Member States are united: vaccine developers have societal and contractual responsibilities they need to uphold.”
“With our Member States, we have requested from AZ a detailed planning of vaccine deliveries and when distribution will take place to Member States,” Kyriakides also said, adding that another meeting with AstraZeneca would be held on Wednesday.
Earlier on Monday, Kyriakides said the pharmaceutical giant’s delays were “not acceptable."
“The European Union has pre-financed the development of the vaccine and its production and wants to see the return,” she also said, adding that the bloc wants to know how many doses the company has produced, and who they’ve been sold to.